Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model Academic Article Article uri icon

Overview

MeSH Major

  • Bile Duct Neoplasms
  • Bile Ducts, Extrahepatic
  • Cholangiocarcinoma
  • Neoplasm Staging
  • Preoperative Care

abstract

  • This neoadjuvant immune strategy may prove useful in reducing the incidence of cancer recurrence after hepatic resection.

publication date

  • May 2000

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1097/00000658-200005000-00017

PubMed ID

  • 10767798

Additional Document Info

start page

  • 762

end page

  • 71

volume

  • 231

number

  • 5